by Age | Cachexia (weight loss) | Complementary and Alternative | Fatigue |
First line | by Grade | by Phase | By Stage
Quality of Life | by Stage | Refractory
or select from menu:
Click to request a trial search
|
by Age
Click here for meaning of Phase I, II, III studies.
|
Investigational therapies for lymphomas:
.gif) |
Children all phases - Phase I | Phase II | Phase III
|
|
Elderly - all phases - Phase I | Phase II | Phase III
|
|
for Cachexia
(cancer-associated weight loss)
Return to top
|
Investigational therapies for :
|
Cachexia
|
|
Complementary &
Alternative Medicine (CAM)
The objective of responsible CAM practices are generally to improve quality of life, general health or performance - or to mitigate the side effects of therapy.
It is unethical to prescribe CAM practices as therapy for lymphoma or other cancers outside of a clinical trial.
Return to top
|
Investigational therapies for lymphomas:
|
CAM studies for lymphoma
|
|
Quality of Life (QOL)
|
|
Fatigue studies
Return to top
|
|
For treatment or lymphoma-related fatigue
|
|
First-line for
previously untreated
"First line" means that participants must have had no prior treatment (or significant treatment), not that the therapy is superior.
Return to top
|
Investigational therapies for previously untreated lymphomas:
Note: This criteria (untreated) is challenging to filter for by query command. Please confirm that the protocols listed are truly for untreated lymphoma by reading the eligibility sections.
|
Trials by subtype and treatment status PDF / Web
|
Treatment-specific first-line studies:
|
Chemotherapy, but not doxorubicin (component of CHOP)
|
|
Excluding chemotherapy or transplants
|
|
Antibodies - excluding chemotherapy or transplants
|
|
Vaccines
|
|
by Grade of Lymphoma
Grade refers to how aggressive or indolent (slow growing) the lymphoma is. Grade I is generally most indolent, and Grade III is most aggressive.
|
Investigational therapies for lymphomas by rate of growth:
|
Grade I | Grade II | Grade III
|
|
Indolent lymphomas
|
|
|
|
Indolent recurrent lymphomas
|
|
Transformed lymphoma (indolent changed to aggressive)
|
|
Aggressive lymphomas
|
|
Aggressive recurrent lymphoma
|
|
by Phase of Study
Click here for meaning
of Phase I, II, III studies.
|
Investigational therapies for lymphomas or CLL:
|
Quality of Life studies
Return to top
|
Investigational therapies for:
|
Quality of Life (QOL)
|
|
by Stage
Stage refers to how widespread the disease is.
|
Investigational therapies for lymphomas:
|
All therapies for all stages -
Stage I | Stage II | Stage III | Stage IV
|
|
Radiotherapy -
Stage I | Stage II | Stage III | Stage IV
|
|
studies for Refractory
Lymphomas
Refractory refers to disease that is resistant to standard treatments.
It is a term without precise definition, however ... in that refractory to therapy A does not mean the lymphoma is not sensitive to therapy B, for example.
|
Studies for refractory (treatment resistant) lymphomas:
|
See also Pipeline for single agents
|
|
Trials by subtype and treatment status PDF / Web
|
|
All Lymphoma
NHL-indolent | NHL - aggressive | Hodgkins | T-cell
|
Treatment-specific studies for refractory lymphomas:
|
Immunotherapy
|
Stem Cell Transplants (SCT):
|
Autologous (stem cells from self)
All lymphomas | CLL/SLL | NHL | Hodgkin's | T-cell
|
|
Allogeneic (stem cells from donor)
All lymphomas | NHL | Hodgkin's | T-cell
|
|
Mini-transplants (stem cells from donor)
All lymphomas | NHL | Hodgkin's | T-cell
(non-myeloablative transplant)
|
|
Refractory AND NOT SCT
All lymphomas | NHL | Hodgkin's | T-cell
|
|
